Saturday, October 19, 2024
2:15 PM - 2:30 PMJoint ILCA-AASLD-CASL SymposiumStrategies for HCC prevention, including in non-viral liver disease
2:30 PM - 2:45 PMJoint ILCA-AASLD-CASL SymposiumEmerging approaches to HCC surveillance
2:45 PM - 3:00 PMJoint ILCA-AASLD-CASL SymposiumPrecision surveillance: close to reality?
3:00 PM - 3:15 PMJoint ILCA-AASLD-CASL SymposiumRecall systems and linkage to care: Important steps after surveillance
3:15 PM - 3:30 PMJoint ILCA-AASLD-CASL SymposiumSystem- and population-level approaches to prevention and surveillance
5:15 PM - 5:25 PMOpening Remarks from CASL President 
5:25 PM - 5:30 PMOpening Remarks from Canadian Liver Foundation 
5:30 PM - 6:00 PMKeynote Speaker LectureState of the Art: Towards an AI-Driven Precision Medicine approach in Hepatocellular Carcinoma
6:00 PM - 7:00 PMWelcome Reception + Networking 
Sunday, October 20, 2024
7:30 AM - 9:00 AMBreakfast 
8:00 AM - 8:45 AMIndustry Breakfast Symposium 
9:00 AMEpidemiology/Diagnosis/Staging - Moderated by  
9:00 AM - 9:15 AMEpidemiology/Diagnosis/StagingEpidemiology: The burden of HCC in Canada
9:15 AM - 9:30 AMEpidemiology/Diagnosis/StagingDiagnostic: The best modality to diagnose HCC
9:30 AM - 9:45 AMEpidemiology/Diagnosis/StagingStaging: Utility of the BCLC staging system
9:45 AM - 10:00 AMEpidemiology/Diagnosis/StagingAdvances in Multidisciplinary Tumor Board Rounds (MTBR)
10:00 AM - 10:15 AMEpidemiology/Diagnosis/StagingQ&A
10:15 AM - 10:45 AMCoffee Break 
10:45 AMEarly & Intermediate HCC - Moderated by 
10:45 AM - 11:00 AMEarly & Intermediate HCCSurgery as first line therapy
11:00 AM - 11:15 AMEarly & Intermediate HCCHow/When/Why liver transplant for HCC
11:15 AM - 11:30 AMEarly & Intermediate HCCThe role of SBRT in HCC management
11:30 AM - 11:45 AMEarly & Intermediate HCCThe role of LRT in HCC cure
11:45 AM - 12:00 PMEarly & Intermediate HCCQ&A
12:00 PM - 1:15 PMLunch 
12:00 PM - 1:15 PMIndustry Lunch Symposium 
1:15 PMLate HCC & Palliative Care - Moderated by 
1:15 PM - 1:30 PMLate HCC & Palliative CarePost transplant management of HCC liver transplant recipients
1:30 PM - 1:45 PMLate HCC & Palliative CareHow to use IO therapy
1:45 PM - 2:00 PMLate HCC & Palliative CareUse of biomarker in predicting response to treatment
2:00 PM - 2:15 PMLate HCC & Palliative CareUtility of Palliative Care in HCC care. When is too early?
2:15 PM - 2:30 PMLate HCC & Palliative CareQ&A
2:30 PM - 3:00 PMAfternoon Break 
3:00 PMFuture Directions - Moderated by  
3:00 PM - 3:15 PMFuture DirectionsThe Importance and Impact of Cancer Research in Canada
3:15 PM - 3:30 PMFuture DirectionsHow to incorporate the patient voice in HCC care
3:30 PM - 3:45 PMFuture DirectionsThe future of AI in HCC
3:45 PM - 4:00 PMFuture DirectionsQ&A
4:00 PM - 4:15 PMClosing Remarks